Connection

Christina Johnson to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Christina Johnson has written about Dose-Response Relationship, Drug.
Christina Johnson
Connection Strength
0.084
Dose-Response Relationship, Drug
  1. Sorafenib activates CD95 and promotes autophagy and cell death via Src family kinases in gastrointestinal tumor cells. Mol Cancer Ther. 2010 Aug; 9(8):2220-31.
    View in: PubMed
    Score: 0.034
  2. MDA-7/IL-24-induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK-dependent mechanism. Mol Cancer Ther. 2009 May; 8(5):1280-91.
    View in: PubMed
    Score: 0.031
  3. Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression. Cancer Biol Ther. 2002 Sep-Oct; 1(5):520-7.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.